IGC Pharma
IGC
#10725
Rank
โ‚ฌ20.48 M
Marketcap
0,18ย โ‚ฌ
Share price
-4.11%
Change (1 day)
-46.68%
Change (1 year)
IGC Pharma, Inc. (formerly India Globalization Capital, Inc.) is a clinical-stage pharmaceutical company focused on developing advanced treatments for diseases, with a primary focus on Alzheimer's disease and other neurological conditions.

Earnings for IGC Pharma (IGC)

Earnings in 2026 (TTM): -โ‚ฌ5.61 Million

According to IGC Pharma's latest financial reports the company's current earnings are โ‚ฌ1.18 Million. In 2025 the company made an earning of -โ‚ฌ4.79 Million, an increase over its 2024 earnings that were of -โ‚ฌ7.89 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for IGC Pharma from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ5.61 Million17.07%
2025 -โ‚ฌ4.79 Million-39.35%
2024 -โ‚ฌ7.89 Million-37.72%
2023 -โ‚ฌ12.67 Million1.19%
2022 -โ‚ฌ12.52 Million21.96%
2021 -โ‚ฌ10.27 Million27.13%
2020 -โ‚ฌ8.08 Million57.16%
2019 -โ‚ฌ5.14 Million85.47%
2018 -โ‚ฌ2.77 Million52.76%
2017 -โ‚ฌ1.82 Million-16.23%
2016 -โ‚ฌ2.17 Million-28.75%
2015 -โ‚ฌ3.04 Million-19.59%
2014 -โ‚ฌ3.78 Million6.79%
2013 -โ‚ฌ3.54 Million-9.47%
2012 -โ‚ฌ3.91 Million-74.03%
2011 -โ‚ฌ15.05 Million119.78%
2010 -โ‚ฌ6.85 Million62.02%
2009 -โ‚ฌ4.23 Million74.39%
2008 -โ‚ฌ2.43 Million-313.12%
2007 โ‚ฌ1.13 M-35.94%
2006 โ‚ฌ1.77 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sterling Infrastructure
STRL
โ‚ฌ0.69 B-12,021.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Trinity Industries
TRN
โ‚ฌ0.65 B-11,253.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Granite Construction
GVA
-โ‚ฌ59.55 Million 915.47%๐Ÿ‡บ๐Ÿ‡ธ USA